Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to help define the role of antibiotics in the treatment of
pediatric skin infections caused by community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA). The investigators hypothesize that treatment with cephalexin, a
penicillin-like antibiotic to which CA-MRSA would be expected to be resistant, does not
result in poorer outcomes than treatment with clindamycin, an antibiotic to which CA-MRSA is
most often susceptible.